Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 16INDUSTRY 7OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 45Neoplasms 27Uterine Cervical Neoplasms 24Prostatic Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Stomach Neoplasms 18Carcinoma, Hepatocellular 16Multiple Myeloma 14Ovarian Neoplasms 11Recurrence 10Pancreatic Neoplasms 10Esophageal Squamous Cell Carcinoma 10Esophageal Neoplasms 9Leukemia, Myeloid, Acute 8Endometrial Neoplasms 8Lymphoma 7Lung Neoplasms 7Brain Neoplasms 7Liver Neoplasms 6Leukemia 6Disease 6Carcinoma, Ovarian Epithelial 6Triple Negative Breast Neoplasms 5Small Cell Lung Carcinoma 5Rectal Neoplasms 5Papillomavirus Infections 5Colonic Neoplasms 5Urinary Bladder Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

toripalimab 1Vinorelbine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × Advanced Breast Cancer × Clear all
NCT07540533 2026-04-20

2025-370

Henan Cancer Hospital

Phase 2 Recruiting
92 enrolled
Breast

Advanced Breast Cancer

NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase â…¡ Clinical Trial

Henan Cancer Hospital

Phase 2 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡